Aurobac Therapeutics
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
29 Avenue Tony Garnier, Lyon, Auvergne-R...Website
www.aurobac-tx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Aurobac Therapeutics
AUROBAC THERAPEUTICS is a biopharmaceutical company focused on developing precision medicines to combat severe bacterial infections, particularly in acute hospital settings. Founded in 2022, the company addresses critical medical needs related to antimicrobial resistance, acute respiratory infections, and sepsis. Their research and development strategy emphasizes patient- and pathogen-targeted programs, alongside innovative diagnostic strategies. The company aims to improve treatment outcomes for patients facing life-threatening conditions associated with antibiotic-resistant infections.Explore more
Aurobac Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aurobac Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Aurobac Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Aurobac Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Aurobac Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Aurobac Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Aurobac Therapeutics
Click to see if Aurobac Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Aurobac Therapeutics has new funding data
Earning: See what the market has to say on Aurobac Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Aurobac Therapeutics as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Aurobac Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aurobac Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aurobac Therapeutics.
Aurobac Therapeutics Tech Stack
A closer look at the technologies used by Aurobac Therapeutics
See more technologies
Most Recent Scoops
Open Position
Hiring Plans
Aurobac Therapeutics has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Open Position
Open Position
Aurobac Therapeutics News & Media
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
Lyon (France), June 3, 2024 AUROBAC THERAPEUTICS, a biopharmaceutical company founded by Boehringer Ingelheim, bioMérieux and Evotec, presented its strategy for the first time today. It aims to address high unmet medical needs associated with infections in acute hospital settings, amidst the growing antimicrobial resistance (AMR) epidemic. AUROBAC THERAPEUTICS’ R&D strategy addresses this urgent need with patient- and pathogen-targeted programs. They are designed to tackle both the causes and coAUROBAC THERAPEUTICS welcomes two new independent members to its Board: Manos Perros, as Chairman, and Marco Taglietti
These new appointments bring extensive US and international experience in company leadership and development of anti-infectives from R&D to commercialization. These new appointments bring extensive US and international experience in company leadership and development of anti-infectives from R&D to commercialization.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aurobac Therapeutics
Sign Up For FreeTo access detailed company insights
AUROBAC THERAPEUTICS is a biopharmaceutical company focused on developing precision medicines to combat severe bacterial infections, particularly in acute hospital settings. Founded in 2022, the company addresses critical medical needs related to antimicrobial resistance, acute respiratory infections, and sepsis. Their research and development stra... Read More
